Table 2:
Cytochrome P-450 (CYPs) and drug metabolism
| Gene | Role | Drug(s) Affected |
|---|---|---|
| CYP2D6 | Metabolism of 25% of all drugs | Antidepressants, antipsychotics, beta blockers, opioids |
| CYP2C9 | Metabolism of 10% of all drugs | Warfarin, NSAIDs, sulfonylureas, phenytoin |
| CYP2C19 | Metabolism of 10–15% of all drugs | Clopidogrel, proton pump inhibitors, citalopram, diazepam |
| CYP1A2 | Metabolism of 9% of all drugs | Clozapine, olanzapine, theophylline, caffeine |
| CYP3A4/3A5 | Metabolism of 50% of all drugs | Statins, benzodiazepenes, antibiotics, antipsychotics |
| SLC6A4 | Serotonin transporter | SSRIs |
| OPRM1 | Mu opioid receptor | Hydromorphone, morphine, oxymorphone, other opioid agonists |
| VKORC1 | Vitamin K clotting cascade | Warfarin (sensitivity) |
| SLCO1B1 | Transport of statins in liver | Statins |
| Factor V (Leiden) | Clotting factor V | Oral contraceptives |
| COMT | Dopamine and norepinephrine degradation | Stimulatory therapies |